NCT04843007 2024-10-23Alvopem® (Pemetrexed) Safety AssessmentNanoAlvandCompleted199 enrolled 21 charts
NCT00497770 2012-05-02An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using PemetrexedEli Lilly and CompanyCompleted434 enrolled 23 charts